» Articles » PMID: 20482878

Sensitization of Cervix Cancer Cells to Adriamycin by Pentoxifylline Induces an Increase in Apoptosis and Decrease Senescence

Abstract

Background: Chemotherapeutic drugs like Adriamycin (ADR) induces apoptosis or senescence in cancer cells but these cells often develop resistance and generate responses of short duration or complete failure. The methylxantine drug Pentoxifylline (PTX) used routinely in the clinics setting for circulatory diseases has been recently described to have antitumor properties. We evaluated whether pretreatment with PTX modifies apoptosis and senescence induced by ADR in cervix cancer cells.

Methods: HeLa (HPV 18+), SiHa (HPV 16+) cervix cancer cells and non-tumorigenic immortalized HaCaT cells (control) were treated with PTX, ADR or PTX + ADR. The cellular toxicity of PTX and survival fraction were determinated by WST-1 and clonogenic assay respectively. Apoptosis, caspase activation and ADR efflux rate were measured by flow cytometry, senescence by microscopy. IkappaBalpha and DNA fragmentation were determinated by ELISA. Proapoptotic, antiapoptotic and senescence genes, as well as HPV-E6/E7 mRNA expression, were detected by time real RT-PCR. p53 protein levels were assayed by Western blot.

Results: PTX is toxic (WST-1), affects survival (clonogenic assay) and induces apoptosis in cervix cancer cells. Additionally, the combination of this drug with ADR diminished the survival fraction and significantly increased apoptosis of HeLa and SiHa cervix cancer cells. Treatments were less effective in HaCaT cells. We found caspase participation in the induction of apoptosis by PTX, ADR or its combination. Surprisingly, in spite of the antitumor activity displayed by PTX, our results indicate that methylxantine, per se does not induce senescence; however it inhibits senescence induced by ADR and at the same time increases apoptosis. PTX elevates IkappaBalpha levels. Such sensitization is achieved through the up-regulation of proapoptotic factors such as caspase and bcl family gene expression. PTX and PTX + ADR also decrease E6 and E7 expression in SiHa cells, but not in HeLa cells. p53 was detected only in SiHa cells treated with ADR.

Conclusion: PTX is a good inducer of apoptosis but does not induce senescence. Furthermore, PTX reduced the ADR-induced senescence and increased apoptosis in cervix cancer cells.

Citing Articles

Very early remission and increased apoptosis with the use of Pentoxifylline in children with acute lymphoblastic leukemia.

Salceda-Rivera V, Ortiz-Lazareno P, Hernandez-Flores G, Vazquez-Urrutia J, Meza-Arroyo J, Pardo-Zepeda M Front Oncol. 2024; 14:1401262.

PMID: 39421449 PMC: 11484046. DOI: 10.3389/fonc.2024.1401262.


Chemosensitizing effect of pentoxifylline in sensitive and multidrug-resistant non-small cell lung cancer cells.

Matos B, Peixoto da Silva S, Vasconcelos M, Xavier C Cancer Drug Resist. 2024; 7:19.

PMID: 38835347 PMC: 11149106. DOI: 10.20517/cdr.2024.04.


Pentoxifylline Inhibits Pulmonary Fibrosis by Regulating Cellular Senescence in Mice.

Lin Y, Xu Z, Zhou B, Ma K, Jiang M Front Pharmacol. 2022; 13:848263.

PMID: 35662697 PMC: 9160723. DOI: 10.3389/fphar.2022.848263.


Sensitizing the cytotoxic action of Docetaxel induced by Pentoxifylline in a PC3 prostate cancer cell line.

Cancino-Marentes M, Hernandez-Flores G, Ortiz-Lazareno P, Villasenor-Garcia M, Orozco-Alonso E, Sierra-Diaz E BMC Urol. 2021; 21(1):38.

PMID: 33711972 PMC: 7953714. DOI: 10.1186/s12894-021-00807-6.


Pentoxifylline Sensitizes Cisplatin-Resistant Human Cervical Cancer Cells to Cisplatin Treatment: Involvement of Mitochondrial and NF-Kappa B Pathways.

Bravo-Cuellar A, Ortiz-Lazareno P, Sierra-Diaz E, Solorzano-Ibarra F, Mendez-Clemente A, Aguilar-Lemarroy A Front Oncol. 2021; 10:592706.

PMID: 33680921 PMC: 7931705. DOI: 10.3389/fonc.2020.592706.


References
1.
Aguilar-Lemarroy A, Gariglio P, Whitaker N, Eichhorst S, Zur Hausen H, Krammer P . Restoration of p53 expression sensitizes human papillomavirus type 16 immortalized human keratinocytes to CD95-mediated apoptosis. Oncogene. 2002; 21(2):165-75. DOI: 10.1038/sj.onc.1204979. View

2.
Li J, Lee B, Lee A . Endoplasmic reticulum stress-induced apoptosis: multiple pathways and activation of p53-up-regulated modulator of apoptosis (PUMA) and NOXA by p53. J Biol Chem. 2006; 281(11):7260-70. DOI: 10.1074/jbc.M509868200. View

3.
Nakanishi C, Toi M . Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs. Nat Rev Cancer. 2005; 5(4):297-309. DOI: 10.1038/nrc1588. View

4.
Herr I, Debatin K . Cellular stress response and apoptosis in cancer therapy. Blood. 2001; 98(9):2603-14. DOI: 10.1182/blood.v98.9.2603. View

5.
Wang C, Cusack Jr J, Liu R, Baldwin Jr A . Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB. Nat Med. 1999; 5(4):412-7. DOI: 10.1038/7410. View